Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matilde Y Follo

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Cancer Research|May 8, 2007
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferationMatilde Y Follo, Sara Mongiorgi, Costanza Bosi, et al.
Journal of Cellular Physiology|October 13, 2016
Nuclear Localization of Diacylglycerol Kinase Alpha in K562 Cells Is Involved in Cell Cycle ProgressionAlessandro Poli, Roberta Fiume, Gianluca Baldanzi, et al.
Endocrinology|November 24, 2006
Inositide-dependent phospholipase C signaling mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin D3 promoterIrene Faenza, Giulia Ramazzotti, Alberto Bavelloni, et al.
International Journal of Molecular Sciences|January 20, 2021
Clinical and Molecular Insights in Erythropoiesis Regulation of Signal Transduction Pathways in Myelodysplastic Syndromes and β-ThalassemiaSarah Parisi, Carlo Finelli, Antonietta Fazio, et al.
Expert Opinion on Therapeutic Targets|November 27, 2015
Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromesSara Mongiorgi, Carlo Finelli, Yong Ryoul Yang, et al.
Cancer Research|March 5, 2004
Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cellsStefania Croci, Lorena Landuzzi, Annalisa Astolfi, et al.
Advances in Biological Regulation|January 27, 2023
Advances in MDS/AML and inositide signallingAlessia De Stefano, Maria Vittoria Marvi, Antonietta Fazio, et al.
Advances in Biological Regulation|November 6, 2017
Nuclear inositide signaling and cell cycleStefano Ratti, Giulia Ramazzotti, Irene Faenza, et al.
Biomolecules|October 26, 2024
Myoblast-Derived Galectin 3 Impairs the Early Phases of Osteogenesis Affecting Notch and Akt ActivityEmanuela Amore, Vittoria Cenni, Manuela Piazzi, et al.
Cells|July 27, 2022
Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer ProgressionJames A McCubrey, Li V Yang, Stephen L Abrams, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Cancer Research|May 8, 2007
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferationMatilde Y Follo, Sara Mongiorgi, Costanza Bosi, et al.
Journal of Cellular Physiology|October 13, 2016
Nuclear Localization of Diacylglycerol Kinase Alpha in K562 Cells Is Involved in Cell Cycle ProgressionAlessandro Poli, Roberta Fiume, Gianluca Baldanzi, et al.
Endocrinology|November 24, 2006
Inositide-dependent phospholipase C signaling mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin D3 promoterIrene Faenza, Giulia Ramazzotti, Alberto Bavelloni, et al.
International Journal of Molecular Sciences|January 20, 2021
Clinical and Molecular Insights in Erythropoiesis Regulation of Signal Transduction Pathways in Myelodysplastic Syndromes and β-ThalassemiaSarah Parisi, Carlo Finelli, Antonietta Fazio, et al.
Expert Opinion on Therapeutic Targets|November 27, 2015
Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromesSara Mongiorgi, Carlo Finelli, Yong Ryoul Yang, et al.
Cancer Research|March 5, 2004
Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cellsStefania Croci, Lorena Landuzzi, Annalisa Astolfi, et al.
Advances in Biological Regulation|January 27, 2023
Advances in MDS/AML and inositide signallingAlessia De Stefano, Maria Vittoria Marvi, Antonietta Fazio, et al.
Advances in Biological Regulation|November 6, 2017
Nuclear inositide signaling and cell cycleStefano Ratti, Giulia Ramazzotti, Irene Faenza, et al.
Biomolecules|October 26, 2024
Myoblast-Derived Galectin 3 Impairs the Early Phases of Osteogenesis Affecting Notch and Akt ActivityEmanuela Amore, Vittoria Cenni, Manuela Piazzi, et al.
Cells|July 27, 2022
Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer ProgressionJames A McCubrey, Li V Yang, Stephen L Abrams, et al.
Pageof 9